← Leaderboards
Paul Sieving
National Institute On Deafness And Other Communication Disorders
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Deafness And Other Communication Disorders
Same institution · by research overlap
Others in their field
Top investigators on “Photoreceptors”
- Krzysztof Palczewski · University Of California-Irvine$48,013,169
- Keri Hammel · The Emmes Company, Llc$41,748,603
- Vadim Y Arshavsky · Massachusetts Eye And Ear Infirmary$27,647,833
- David R Williams · University Of Rochester$25,998,477
- Ehud Isacoff · University Of California Berkeley$25,320,732
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
PhotoreceptorsGenesRetinalMembraneRetinaStructureMutationInheritedBaseProteinsCellsAnimal ModelSignal TransductionTherapy DevelopmentFunctional DisorderClinicTherapeutic InterventionHuman DiseaseLightAffectElectroretinographyMouse ModelMacular DegenerationVision
Grant awards (25)
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$964,570
ZIA · FY2019 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$385,828
ZIA · FY2019 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$389,538
ZIA · FY2018 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$137,614
ZIA · FY2017 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$294,154
ZIA · FY2016 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$117,661
ZIA · FY2016 · DC · contact PI
Preclinical and Clinical Study of CNGb3 Acromatopsia and Treatment with CNTF$809,392
ZIA · FY2015 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$289,069
ZIA · FY2015 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$115,627
ZIA · FY2015 · DC · contact PI
Preclinical and Clinical Study of CNGb3 Acromatopsia and Treatment with CNTF$809,392
ZIA · FY2014 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$289,069
ZIA · FY2014 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$115,627
ZIA · FY2014 · DC · contact PI
Preclinical and Clinical Study of CNGb3 Acromatopsia and Treatment with CNTF$792,080
ZIA · FY2013 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$282,886
ZIA · FY2013 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$113,154
ZIA · FY2013 · DC · contact PI
Preclinical and Clinical Study of CNGb3 Acromatopsia and Treatment with CNTF$811,659
ZIA · FY2012 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$289,878
ZIA · FY2012 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$115,951
ZIA · FY2012 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$881,429
ZIA · FY2011 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$352,571
ZIA · FY2011 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$753,815
ZIA · FY2010 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$568,668
ZIA · FY2010 · DC · contact PI
Pathophysiology and Treatment of Retinal Degenerations in Animal Models$645,240
ZIA · FY2009 · DC · contact PI
Preclinical and Clinical Development of Treatment for X-linked Retinoschisis$486,760
ZIA · FY2009 · DC · contact PI
Mechanisms and treatment of retinal degeneration in animal models and humans$2,471,232
Z01 · FY2008 · DC · contact PI